DJIA 15,500.84 113.26 0.74%
NASDAQ 3,522.34 20.22 0.58%
S&P 500 1,681.04 11.88 0.71%

company name or ticker

SmithOnStocks Opines On Stocks: May 19th Edition

Cheerleaders: Look Beyond Pharma For Jobs

Benzinga's Top Downgrades

Transcept Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript

Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog

Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog

Impax Beats Earnings Estimate - Analyst Blog

AMAG Narrows Loss; Maintains View - Analyst Blog

Merck - BMY in HCV Deal - Analyst Blog

Merck - BMY in HCV Deal - Analyst Blog

Merck In-Licenses from Xenon - Analyst Blog

Merck In-Licenses from Xenon - Analyst Blog

Sanofi's Vaccine Gets EU Approval - Analyst Blog

See More Articles...